GSK2982772
Drug timelines are a Plus or Pro feature.
9 regulatory and trial events tracked for GSK2982772, covering 2017-05-09 to 2024-03-18. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Benefit and Safety of GSK2982772 in Moderate to Severe Psoriasis Participants [Phase 1]